Sky Medical Partners with SMS Medical to Enhance Post-Surgical Recovery with geko® Device

New Distribution Agreement: Sky Medical and SMS Medical

In a significant move to advance postoperative care, Sky Medical Technology has formed a distributor agreement with SMS Medical. This collaboration will see the introduction of the geko® device in the United States, aiming to address critical issues related to edema (swelling) and prevent deep vein thrombosis (DVT) in patients recovering from various orthopedic surgeries.

The geko® device stands out as a first-of-its-kind muscle pump activator, clinically validated to effectively minimize lower leg swelling, which can notably complicate recovery and heighten the risk of surgical site infections (SSI) following elective orthopedic procedures. Additionally, it also provides essential prophylaxis against DVT, a common risk for patients who are immobile or medically compromised post-surgery.

The agreement integrates the geko® device into the extensive range of orthopedic solutions provided by SMS Medical, recognized as a leader in the southeastern U.S. orthopedic device market. This collaboration will enhance the recovery protocols following procedures such as total hip and knee arthroplasties and manage trauma-related conditions affecting the lower extremities.

Joseph Collins, Vice President of Business Development at SMS Medical, expressed enthusiasm about the partnership, emphasizing the impact of edema on patient recovery. "The geko device’s ability to clinically reduce swelling positions it as a revolutionary tool in our orthopedic arsenal, contributing to better outcomes and decreased healthcare costs."

Similarly, Bernard Ross, the Founder and CEO of Sky Medical, articulated pride in the partnership with SMS Medical. He highlighted the collective commitment to improving patient recovery following surgery, paving the way for future advancements in orthopedic care. This partnership promises to deliver impactful results for both surgeons and patients, aiming for better health results while simultaneously lowering healthcare system burdens.

Introduction of the geko® Device

The geko® device utilizes a unique neuromuscular electrostimulation (NMES) mechanism, applied non-invasively to the skin over the common peroneal nerve near the knee. This innovative technology stimulates the nerve once every second, activating the calf and foot muscle pumps, which facilitates blood flow in the deep veins at a rate comparable to 60% of walking, without requiring the patient to move. This effective method serves to reduce fluid leakage from the capillary beds, enhancing lymphatic function and encouraging the clearance of excess interstitial fluid, which is pivotal in managing edema and reducing the risk of DVT.

SMS Medical is looking to introduce the geko® device to targeted markets across the U.S. in the early quarters of 2025. Through this initiative, they aim to make strides in enhancing patient care in orthopedic settings. For insights or inquiries into the geko® technology, interested parties can reach out to Mark Sacaris, President of US Operations, or visit the official site at www.gekodevices.com/US.

Conclusion

This partnership between Sky Medical Technology and SMS Medical marks a pivotal change in orthopedics, showcasing a shared vision of delivering enhanced medical solutions for post-operative care. The commitment to improving patient outcomes and reducing healthcare expenditure underlines the significant potential of the geko® device, destined to become a cornerstone in the recovery of patients undergoing various orthopedic interventions.